Galantamine hydrobromide
- Product NDC
- 43353-984
- 11-digit product format
- 433530984
- Labeler code
- 43353
- Product ID
- 43353-984_ee9210aa-aedf-4658-bd12-0710ee2e54b8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Galantamine hydrobromide
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA079028
- Marketing category
- ANDA
- Marketing start
- 2009-12-15
- Marketing end
- 0000-00-00
- Substance
- GALANTAMINE HYDROBROMIDE
- Active strength
- 16 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-984 | GALANTAMINE HYDROBROMIDE CAPSULE, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20160715_9a04069a-02e2-4428-a73f-51e58b51af89.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-984-05 | 43353098405 | 4200 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43353-984-05) | 2015-11-15 | 0000-00-00 | No | No | Current |